Furthermore, compounds that inhibit cdk5‐mediated PPARγ Ser273 phosphorylation have shown promise in reducing insulin resistance (Dias et al. 2020; Haas et al. 2024). The gene discussed is CDK5; the disease is Insulin resistance.